Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Decapeptyl SR plus Livial add-back therapy for chronic cyclical pelvic pain
2007-001159-20Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Oct 2008
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of triptorelin and tibolone in chronic prostatitis (CP), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Impact of treatment on chronic cyclical pelvic pain throughout the 24-month treatment period. Started Oct 2008; status: completed.
02
Drugs
triptorelintibolone
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on 2007-001159-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001159-20.